Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| smooth muscle cell | 15 studies | 30% ± 9% | |
| pericyte | 10 studies | 25% ± 9% | |
| fibroblast | 6 studies | 23% ± 7% | |
| myofibroblast cell | 4 studies | 31% ± 8% | |
| connective tissue cell | 3 studies | 24% ± 5% |
Insufficient scRNA-seq data for expression of MRGPRF at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| prostate | 97% | 3815.14 | 237 / 245 | 98% | 22.05 | 494 / 502 |
| ovary | 94% | 2815.02 | 169 / 180 | 82% | 6.19 | 351 / 430 |
| bladder | 100% | 5745.00 | 21 / 21 | 72% | 7.91 | 363 / 504 |
| intestine | 89% | 7543.76 | 863 / 966 | 81% | 8.66 | 427 / 527 |
| uterus | 100% | 11701.58 | 170 / 170 | 65% | 13.36 | 297 / 459 |
| breast | 96% | 2660.58 | 440 / 459 | 69% | 4.18 | 769 / 1118 |
| esophagus | 86% | 6334.42 | 1236 / 1445 | 78% | 7.35 | 142 / 183 |
| lung | 88% | 1417.77 | 507 / 578 | 75% | 7.87 | 866 / 1155 |
| stomach | 61% | 3004.83 | 220 / 359 | 82% | 13.96 | 234 / 286 |
| skin | 70% | 1086.74 | 1270 / 1809 | 41% | 2.11 | 195 / 472 |
| ureter | 0% | 0 | 0 / 0 | 100% | 11.35 | 1 / 1 |
| blood vessel | 100% | 6020.12 | 1329 / 1335 | 0% | 0 | 0 / 0 |
| kidney | 74% | 979.47 | 66 / 89 | 25% | 1.56 | 228 / 901 |
| adipose | 97% | 3283.07 | 1171 / 1204 | 0% | 0 | 0 / 0 |
| pancreas | 0% | 2.51 | 1 / 328 | 91% | 10.72 | 162 / 178 |
| thymus | 52% | 694.49 | 342 / 653 | 25% | 1.19 | 152 / 605 |
| brain | 13% | 154.79 | 356 / 2642 | 55% | 3.58 | 388 / 705 |
| spleen | 60% | 811.73 | 145 / 241 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 55% | 1.77 | 16 / 29 |
| tonsil | 0% | 0 | 0 / 0 | 53% | 2.85 | 24 / 45 |
| liver | 3% | 30.75 | 7 / 226 | 40% | 5.05 | 164 / 406 |
| eye | 0% | 0 | 0 / 0 | 33% | 1.24 | 26 / 80 |
| heart | 28% | 306.70 | 237 / 861 | 0% | 0 | 0 / 0 |
| adrenal gland | 3% | 34.46 | 8 / 258 | 22% | 1.17 | 50 / 230 |
| muscle | 3% | 37.63 | 26 / 803 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0007186 | Biological process | G protein-coupled receptor signaling pathway |
| GO_0031965 | Cellular component | nuclear membrane |
| GO_0005886 | Cellular component | plasma membrane |
| GO_0004930 | Molecular function | G protein-coupled receptor activity |
| Gene name | MRGPRF |
| Protein name | Mas-related G-protein coupled receptor member F (Mas-related gene F protein) (G-protein coupled receptor 140) (G-protein coupled receptor 168) Mas-related G protein-coupled receptor F MAS related GPR family member F |
| Synonyms | GPR168 GPR140 MRGF PSEC0142 |
| Description | FUNCTION: Orphan receptor. May bind to a neuropeptide and may regulate nociceptor function and/or development, including the sensation or modulation of pain (By similarity). . |
| Accessions | ENST00000309099.7 A0A2I4R878 F5H5R4 Q96AM1 ENST00000320913.6 |
